Cell-based Assays
IBR Inc. has a longstanding experience in development, validation and operating cell-based assays. Our expertise covers bioassays using primary cells. These cells are isolated from a broad variety of human or mammalian tissues.
Depending on the application, primary cells are considered to deliver more physiological responses than transformed cell lines. However, primary cells are demanding with regard to cell culture and handling. The IBR Inc. scientists have know-how in management of primary cells to provide you with reliable and precise potency assays as well as mode of action assessments.
In addition, IBR Inc. offers bioassays using transformed cell lines and reporter gene assays. The services of IBR Inc. include a broad variety of endpoints like cell growth / apoptosis, cell signaling, migration & invasion, adhesion and many more.
The broad panel of IBR Inc.'s cell-based assays supports your drug developmental program from pre-clinical to clinical development. The cell-based assay services are also provided under the GxP Quality standards.
IBR Inc. invites you to discuss your special needs with our experts.
Our technologies for cell-based assays
IBR Inc. sets high value on state-of the-art technologies for cell-based assays. For the readout of assay endpoints we offer single or multiplex formats. Leveraging a wide choice of readers and advanced technology platforms (see below) we are confident to provide you with cell-based assays tailored to your specific requirements.
Our readers:
EnSpire
MRX
Our advanced technologies:
BD FACSLyric
MSD ECL
Time-Resolved Fluorescence (TRF), TR-FRET, Alpha
Submit a Question or Request
Simply fill out the form below and a member of our team will follow up with you shortly.